Response of renal cell carcinoma pancreatic metastasis to sunitinib treatment: a retrospective analysis
J Medioni, TK Choueiri, F Zinzindohoué, D Cho… - The Journal of …, 2009 - Elsevier
PURPOSE: Pancreatic metastasis accounts for 2% of metastatic renal cell carcinoma cases.
Surgical management is typically recommended because of the limited value of
immunotherapy as an effective treatment. Sunitinib recently showed clinical efficacy in
patients with advanced renal cell carcinoma. We report a series of patients with pancreatic
metastasis treated with sunitinib. MATERIALS AND METHODS: We retrospectively studied a
population of 15 adults with pancreatic metastasis of renal cell carcinoma at 1 center in …
Surgical management is typically recommended because of the limited value of
immunotherapy as an effective treatment. Sunitinib recently showed clinical efficacy in
patients with advanced renal cell carcinoma. We report a series of patients with pancreatic
metastasis treated with sunitinib. MATERIALS AND METHODS: We retrospectively studied a
population of 15 adults with pancreatic metastasis of renal cell carcinoma at 1 center in …